Skip to main content

Peer Review reports

From: Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Original Submission
13 Aug 2017 Submitted Original manuscript
25 Aug 2017 Reviewed Reviewer Report - Hari Ananthula
11 Sep 2017 Reviewed Reviewer Report - Alfred Balch
22 Sep 2017 Author responded Author comments - Pravesh Kumar Bundhun
Resubmission - Version 2
22 Sep 2017 Submitted Manuscript version 2
15 Oct 2017 Editorially accepted
23 Oct 2017 Article published 10.1186/s40360-017-0175-0

You can find further information about peer review here.

Back to article page